In 2009, Chen, Xinchun et al. developed an in-house IFN-γ enzyme-linked immunospot (ELISPOT) assay and evaluated its value in the diagnosis of active tuberculosis (TB) in Shenzhen, China [10]. This evidence concerns the gene IFNG and tuberculosis.